SCHEMBL7088362

SCHEMBL7088362

CC(C)Oc1ccccc1C(=O)c1ccccc1OC(C)C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.72
ALDH1A1 P00352 2/20 0.58
ACHE P22303 1/20 0.58
ELANE P08246 2/20 0.52
IDO1 P14902 1/20 0.51
TDO2 P48775 1/20 0.51
KCNK3 O14649 2/20 0.49
KCNK9 Q9NPC2 2/20 0.49
KDM4E B2RXH2 3/20 0.49
LMNA P02545 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
KMT2A Q03164 1/20 0.47
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
PRMT5 O14744 1/20 0.44
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MRGPRX1 Q96LB2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27694472 0.89 IRAK4 (0.64) IRAK4ALDH1A1ACHEELANEIDO1
SCHEMBL20496425 0.88 IRAK4 (0.58) IRAK4ALDH1A1ACHEELANEIDO1
SCHEMBL20496480 0.88 IRAK4 (0.58) IRAK4ALDH1A1ACHEELANEIDO1
SCHEMBL2094692 0.88 IRAK4 (0.72) IRAK4ALDH1A1ACHEIDO1TDO2
SCHEMBL28293902 0.86 IRAK4 (0.70) IRAK4ALDH1A1ACHEIDO1TDO2
SCHEMBL104892 0.86 IRAK4 (0.70) IRAK4ALDH1A1ACHEIDO1TDO2
SCHEMBL2103513 0.84 IRAK4 (1.00) IRAK4ALDH1A1ACHEIDO1TDO2
Bicarbonate SCHEMBL21811920 0.84 IRAK4 (0.68) IRAK4ALDH1A1ACHEIDO1TDO2
SCHEMBL16674268 0.84 IRAK4 (0.68) IRAK4ALDH1A1ACHEIDO1TDO2
SCHEMBL2094687 0.84 IRAK4 (0.68) IRAK4ALDH1A1ACHEIDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171422-A1 New nitromethyl ketones, process for preparing them and compositions containing them MERCK PATENT GMBH (DE) 2003-09-11 US disclosed
US-6559185-B2 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use MERCK PATENT GMBH (DE) 2003-05-06 US disclosed
US-20030069312-A1 Antidiabetic agents LARDY CLAUDE (FR) 2003-04-10 US disclosed
US-6043281-A ALDOSE REDUCTASE INHIBITORS; TREATMENT OR PREVENTION OF COMPLICATIONS OF DIABETES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-03-28 US disclosed
EP-0983226-A1 NEW NITROMETHYL KETONES, PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM MERCK PATENT GmbH (DE) 2000-03-08 EP disclosed
US-5932765-A REDUCTASE INHIBITORS MERCK PATENT GESELLSCHAFT MIT (DE) 1999-08-03 US disclosed
WO-1998052906-A1 NEW NITROMETHYL KETONES, PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM MERCK PATENT GMBH (DE) 1998-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069312-A1 Antidiabetic agents SLC5A1, SLC5A2, GPR119 IRAK4 3669/4885ALDH1A1 33/4885ACHE 2312/4885
US-20030171422-A1 New nitromethyl ketones, process for preparing them and compositions containing them AKR1B1, AKR1A1, AKR1C1 IRAK4 3324/4885ALDH1A1 63/4885ACHE 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.